4th Quarter - Termination
POLICY ADVOCATES for GLAXOSMITHKLINE
Firm
Client
Income
$20,000
Expenses
—
Terminated
Dec 31, 2018
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Obamacare Repeal Health Care reform Chip Reauthorization
| Lobbyist | Covered position, as disclosed |
|---|---|
| VICTOR CABRAL | — |
Medicare/Medicaid MMM
Health Care Reform Legislation HR1628 Access to Affordable Prescription Drugs Medicare Prescription Drug Price Negotiation Act HR 242 Protecting Medicare from executive Action S 251 Medicare Prescription Drug Price Negotiation Act S 41 Race for Children Act HR 1231
| Lobbyist | Covered position, as disclosed |
|---|---|
| VICTOR CABRAL | — |
Trade (domestic/foreign) TRD
USTR appointments Patent Protection NAFTA repeal and Renegotiation
| Lobbyist | Covered position, as disclosed |
|---|---|
| VICTOR CABRAL | — |
Taxation/Internal Revenue Code TAX
Corporate Tax Reform Excise Tax Issues Health Care Extenders
| Lobbyist | Covered position, as disclosed |
|---|---|
| VICTOR CABRAL | — |
Copyright/Patent/Trademark CPT
Monitor Patent issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| VICTOR CABRAL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.